<DOC>
	<DOCNO>NCT00685516</DOCNO>
	<brief_summary>RATIONALE : Green tea contain ingredient may prevent slow growth certain cancer . It yet know whether green tea effective black tea water treat prostate cancer . PURPOSE : This randomized phase II trial study green tea see well work compare black tea water treat patient prostate cancer undergo surgery .</brief_summary>
	<brief_title>Green Tea , Black Tea , Water Treating Patients With Prostate Cancer Undergoing Surgery</brief_title>
	<detailed_description>OBJECTIVES : - determine effect GT BT consumption apoptosis ( TUNEL , ratio Bax : Bcl-2 ) , proliferation , oxidation , inflammation malignant radical prostatectomy tissue compare water control use immunohistochemistry . - examine level tea polyphenols methylated tea polyphenol metabolite fresh frozen radical prostatectomy tissue urine , urinary oxidative DNA damage ( 8OHdG ) serum prostate-specific antigen ( PSA ) level . OUTLINE : This multicenter , randomize study . Patients randomize 1 3 treatment arm . - Arm I : Patients receive 6 cup green tea daily 2-8 week absence unacceptable toxicity . - Arm II : Patients receive 6 cup water daily 2-8 week absence unacceptable toxicity . - Arm III : Patients receive 6 cup decaffeinate black tea daily 2-8 week absence unacceptable toxicity . Patients undergo radical prostatectomy . Blood urine sample , well tissue diagnostic biopsy radical prostatectomy specimen , obtain laboratory correlative study . Samples assess IHC , high-performance liquid chromatography , mass spectrometry change prostate tumor grade , stage , margin status ; concentration total free tea polyphenols ( i.e. , EGCG , EC , EGC , ECG ) , theaflavins , conjugated/colonic tea metabolite ; biomarkers prostate cancer development progression ( i.e. , serum PSA , proliferation [ i.e. , Ki-67 ] , apoptosis [ i.e. , TUNEL , Bax/Bcl-2 ratio ] , inflammation [ i.e. , NFkB ] ) , oxidative status ( i.e. , 8OhdG/dG ratio ) ; genotype gene expression metabolize enzyme ( i.e. , COMT , UGT , SULT ) . Serum sample also assess ex vivo LNCaP cell culture assay antiproliferative activity competitive chemiluminescent immunoassay concentration PSA , IGF-1 , IGFBP-3 , testosterone , SHBG , DHEA-sulfate .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>subject consent participate trial . subject 4075 year age diagnosis adenocarcinoma prostate . Scheduled undergo radical prostatectomy . The subject agree stop consumption tea teacontaining product throughout entire intervention period except tea provide study intervention . The subject agree stop consumption dietary vitamin supplement ( e.g. , lycopene , Vitamin E , selenium , genistein ) herbal supplement ( e.g. , saw palmetto , PCSPES ) history hepatitis liver dysfunction ongoing alcohol abuse significant medical psychiatric condition would make patient poor protocol candidate prior sensitivity allergic reaction tea , tea product , tea supplement allergy sensitivity multiple food item nutritional supplement concurrent luteinizing hormonereleasing hormone agonist , androgen receptor block agent , finasteride prior bilateral orchiectomy</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage II prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>